|
Martinez-Vicente I, Abrisqueta M, Herraiz C, Jimenez-Cervantes C, Garcia-Borron JC, Olivares C. Functional characterization of a C-terminal splice variant of the human melanocortin 1 receptor. Exp Dermatol. 2020 Jul;29(7):610-615. doi: 10.1111/exd.14118. Epub 2020 Jun 15. PubMed PMID: 32474972.
AÑO: 2020; IF: 3.96
|
32474972
|
Martinez-Morcillo FJ, Canton-Sandoval J, Martinez-Navarro FJ, Cabas I, Martinez-Vicente I, Armistead J, Hatzold J, Lopez-Munoz A, Martinez-Menchon T, Corbalan-Velez R, Lacal J, Hammerschmidt M, Garcia-Borron JC, Garcia-Ayala A, Cayuela ML, Perez-Oliva AB, Garcia-Moreno D, Mulero V. NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death. PLoS Biol. 2021 Nov 8;19(11):e3001455. doi: 10.1371/journal.pbio.3001455. eCollection 2021 Nov. PubMed PMID: 34748530; PubMed Central PMCID: PMC8601609.
AÑO: 2021; IF: 9.593
|
|
Sires-Campos J, Lambertos A, Delevoye C, Raposo G, Bennett DC, Sviderskaya E, Jimenez-Cervantes C, Olivares C, Garcia-Borron JC. Mahogunin Ring Finger 1 regulates pigmentation by controlling the pH of melanosomes in melanocytes and melanoma cells. Cell Mol Life Sci. 2021 Dec 18;79(1):47. doi: 10.1007/s00018-021-04053-9. PubMed PMID: 34921635; PubMed Central PMCID: PMC8738503.
AÑO: 2021; IF: 9.207
|
|
Abrisqueta M, Cerdido S, Sanchez-Beltran J, Martinez-Vicente I, Herraiz C, Lambertos A, Olivares C, Sevilla A, Alonso S, Boyano MD, Garcia-Borron JC, Jimenez-Cervantes C. MGRN1 as a Phenotypic Determinant of Human Melanoma Cells and a Potential Biomarker. Life (Basel). 2022 Jul 26;12(8):1118. doi: 10.3390/life12081118. PubMed PMID: 35892921; PubMed Central PMCID: PMC9331370.
AÑO: 2022; IF: 3.251
|
|
Cerdido S, Abrisqueta M, Sanchez-Beltran J, Lambertos A, Castejon-Grinan M, Munoz C, Olivares C, Garcia-Borron JC, Jimenez-Cervantes C, Herraiz C. MGRN1 depletion promotes intercellular adhesion in melanoma by upregulation of E-cadherin and inhibition of CDC42. Cancer Lett. 2024 Jan 28;581:216484. doi: 10.1016/j.canlet.2023.216484. Epub 2023 Nov 25. PubMed PMID: 38008393.
AÑO: 2024; IF: 9.1
|